A PhaseⅡ of Injection for Recombinant Human Tissue Plasminogen Kinase Derivative in Treatment of Acute Ischemic Stroke.
Clinical trial NCT04028518 · UNKNOWN
Trial details
- NCT number
- NCT04028518
- Sponsor
- Angde Biotech Pharmaceutical Co., Ltd.
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-07-20
- Primary completion
- 2020-10-31
- Enrollment
- 180
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.